• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本幽门螺杆菌分离株中cag致病岛的结构

Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates.

作者信息

Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, Shiratori Y, Omata M

机构信息

Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.

出版信息

Gut. 1999 Mar;44(3):336-41. doi: 10.1136/gut.44.3.336.

DOI:10.1136/gut.44.3.336
PMID:10026317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1727424/
Abstract

BACKGROUND

cag pathogenicity island (PAI) is reported to be a major virulence factor of Helicobacter pylori.

AIM

To characterise cagA and the cag PAI in Japanese H pylori strains.

METHODS

H pylori isolates from Japanese patients were evaluated for CagA by immunoblot, for cagA transcription by northern blot, and for cagA and 13 other cag PAI genes by Southern blot. cagA negative strains from Western countries were also studied. Induction of interleukin-8 secretion from gastric epithelial cells was also investigated.

RESULTS

All Japanese strains retained cagA. Fifty nine of 63 (94%) strains had all the cag PAI genes. In the remaining four, cag PAI was partially deleted, lacking cagA transcripts and not producing CagA protein. Details of the PAI of these strains were checked; three lacked cagB to cagQ (cagI) and continuously cagS to cag13 (cagII), and the remaining one lacked cagB to cag8. Western cagA negative strains completely lacked cag PAI including cagA. Nucleotide sequence analysis in one strain in which the cag PAI was partially deleted showed that the partial deletion contained 25 kb of cag PAI and the cagA promoter. Interleukin-8 induction was lower with the cag PAI partial deletion strains than with the intact ones. All Japanese cag PAI deleted strains were derived from patients with non-ulcer dyspepsia, whereas 41 of 59 (70%) CagA-producing strains were from patients with peptic ulcers or gastric cancer (p<0.05).

CONCLUSIONS

Most Japanese H pylori strains had the intact cag PAI. However, some lacked most of the cag PAI in spite of the presence of cagA. Thus the presence of the cagA gene is not an invariable marker of cag PAI related virulence in Japanese strains.

摘要

背景

据报道,细胞毒素相关基因A(cagA)致病岛(PAI)是幽门螺杆菌的主要毒力因子。

目的

对日本幽门螺杆菌菌株中的cagA和cag PAI进行特征分析。

方法

通过免疫印迹法评估来自日本患者的幽门螺杆菌分离株的CagA,通过Northern印迹法评估cagA转录情况,通过Southern印迹法评估cagA和其他13个cag PAI基因。还对来自西方国家的cagA阴性菌株进行了研究。同时研究了胃上皮细胞白细胞介素-8分泌的诱导情况。

结果

所有日本菌株均保留cagA。63株中有59株(94%)具有所有cag PAI基因。其余4株中,cag PAI部分缺失,缺乏cagA转录本且不产生CagA蛋白。检查了这些菌株PAI的详细情况;3株缺乏cagB至cagQ(cagI)以及连续的cagS至cag13(cagII),其余1株缺乏cagB至cag8。西方cagA阴性菌株完全缺乏包括cagA在内的cag PAI。对一株cag PAI部分缺失的菌株进行核苷酸序列分析表明,部分缺失包含25 kb的cag PAI和cagA启动子。cag PAI部分缺失菌株的白细胞介素-8诱导作用低于完整菌株。所有日本cag PAI缺失菌株均来自非溃疡性消化不良患者,而59株产生CagA的菌株中有41株(70%)来自消化性溃疡或胃癌患者(p<0.05)。

结论

大多数日本幽门螺杆菌菌株具有完整的cag PAI。然而,一些菌株尽管存在cagA,但大部分cag PAI缺失。因此,在日本菌株中,cagA基因的存在并非cag PAI相关毒力的恒定标志物。

相似文献

1
Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates.日本幽门螺杆菌分离株中cag致病岛的结构
Gut. 1999 Mar;44(3):336-41. doi: 10.1136/gut.44.3.336.
2
[High prevalence of VacA, CagA protein expression and presence of cag pathogenicity island in Japanese Helicobacter pylori isolates].[日本幽门螺杆菌分离株中VacA、CagA蛋白表达的高流行率及cag致病岛的存在情况]
Nihon Rinsho. 1999 Jan;57(1):17-22.
3
Intact cag pathogenicity island of Helicobacter pylori without disease association in Kolkata, India.印度加尔各答的幽门螺杆菌完整 cag 致病岛与疾病无关。
Int J Med Microbiol. 2011 Apr;301(4):293-302. doi: 10.1016/j.ijmm.2010.10.003. Epub 2010 Dec 30.
4
Low prevalence of the intact cag pathogenicity island in clinical isolates of Helicobacter pylori in Karachi, Pakistan.巴基斯坦卡拉奇幽门螺杆菌临床分离株中完整cag致病岛的低流行率。
Br J Biomed Sci. 2009;66(3):137-42. doi: 10.1080/09674845.2009.11730260.
5
Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia.幽门螺杆菌cag致病岛的基因多样性及其对英国消化不良患者抗CagA血清抗体表达的影响。
J Clin Pathol. 2001 Mar;54(3):219-23. doi: 10.1136/jcp.54.3.219.
6
Analyses of the cag pathogenicity island of Helicobacter pylori.幽门螺杆菌cag致病岛的分析
Mol Microbiol. 1998 Apr;28(1):37-53. doi: 10.1046/j.1365-2958.1998.00770.x.
7
implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion.幽门螺杆菌cag致病岛结构在诱导白细胞介素-8分泌中的作用
Infect Immun. 2001 Mar;69(3):1625-9. doi: 10.1128/IAI.69.3.1625-1629.2001.
8
Molecular epidemiology of Helicobacter pylori in England: prevalence of cag pathogenicity island markers and IS605 presence in relation to patient age and severity of gastric disease.英格兰幽门螺杆菌的分子流行病学:cag致病岛标志物的流行情况及IS605的存在与患者年龄和胃部疾病严重程度的关系
FEMS Immunol Med Microbiol. 2001 Feb;30(1):65-71. doi: 10.1111/j.1574-695X.2001.tb01551.x.
9
The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations.在来自不同人群的大多数患者分离株中,幽门螺杆菌的cag致病岛被破坏。
J Clin Microbiol. 2004 Nov;42(11):5302-8. doi: 10.1128/JCM.42.11.5302-5308.2004.
10
Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island.通过对cag致病岛进行简单基因分析来确定幽门螺杆菌的毒力
Clin Diagn Lab Immunol. 2001 Jan;8(1):181-6. doi: 10.1128/CDLI.8.1.181-186.2001.

引用本文的文献

1
Validation of the ABC Method for Gastric Cancer Risk Stratification Across Helicobacter pylori Infections With Diverse CagA Status and Subtypes in Brazil.巴西针对幽门螺杆菌不同CagA状态和亚型感染的胃癌风险分层ABC方法的验证
Cancer Med. 2025 Jul;14(13):e71016. doi: 10.1002/cam4.71016.
2
Helicobacter pylori cagA, vacA, and iceA genotypes and clinical outcomes: a cross-sectional study in central Vietnam.越南中部的一项横断面研究:幽门螺杆菌 cagA、vacA 和 iceA 基因型与临床结局的关系。
Braz J Microbiol. 2024 Jun;55(2):1393-1404. doi: 10.1007/s42770-024-01328-8. Epub 2024 Apr 27.
3
Histomolecular profile of strains circulating in Brazzaville (Congo).在布拉柴维尔(刚果)传播的菌株的组织分子特征。
JGH Open. 2024 Feb 15;8(2):e13035. doi: 10.1002/jgh3.13035. eCollection 2024 Feb.
4
Relationship between virulence genes and gastroduodenal disease.毒力基因与胃十二指肠疾病的关系。
J Int Med Res. 2023 Mar;51(3):3000605231161465. doi: 10.1177/03000605231161465.
5
Correlation analysis of gastric mucosal lesions with infection and its virulence genotype in Guiyang, Guizhou province, China.中国贵州省贵阳市胃黏膜病变与感染及其毒力基因型的相关性分析
Ann Transl Med. 2022 Dec;10(24):1320. doi: 10.21037/atm-22-5553.
6
Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.**临床相关性**:**cagA** 和 **vacA s1m1 状态** 与 **幽门螺杆菌** 抗生素耐药性:系统评价和荟萃分析。
BMC Infect Dis. 2022 Jun 25;22(1):573. doi: 10.1186/s12879-022-07546-5.
7
EPIYA motifs of genotypes and gastrointestinal diseases in the Iranian population: a systematic review and meta-analysis.伊朗人群中基因型的EPIYA基序与胃肠道疾病:一项系统评价和荟萃分析。
New Microbes New Infect. 2021 Mar 16;41:100865. doi: 10.1016/j.nmni.2021.100865. eCollection 2021 May.
8
Genetic variation in the cag pathogenicity island of Helicobacter pylori strains detected from gastroduodenal patients in Thailand.在泰国的胃十二指肠患者中检测到的幽门螺杆菌菌株 cag 致病岛的遗传变异。
Braz J Microbiol. 2020 Sep;51(3):1093-1101. doi: 10.1007/s42770-020-00292-3. Epub 2020 May 15.
9
Presence of genes and characterization of s, i and m regions in isolated from Alaskans and their association with clinical pathologies.从阿拉斯加人分离出的 中 基因的存在及其 s、i 和 m 区的特征与临床病理学的关系。
J Med Microbiol. 2020 Feb;69(2):218-227. doi: 10.1099/jmm.0.001123. Epub 2020 Feb 3.
10
Role of Plasticity Region Genes and cagE gene of cagPAI of Helicobacter pylori in Development of Gastrointestinal (GI) Diseases.幽门螺杆菌cagPAI的可塑性区域基因和cagE基因在胃肠道疾病发生发展中的作用
Asian Pac J Cancer Prev. 2017 Jan 1;18(1):43-49. doi: 10.22034/APJCP.2017.18.1.43.

本文引用的文献

1
Analyses of the cag pathogenicity island of Helicobacter pylori.幽门螺杆菌cag致病岛的分析
Mol Microbiol. 1998 Apr;28(1):37-53. doi: 10.1046/j.1365-2958.1998.00770.x.
2
Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan.主要毒力因子VacA和CagA在日本分离出的幽门螺杆菌菌株中通常呈阳性。
Gut. 1998 Mar;42(3):338-43. doi: 10.1136/gut.42.3.338.
3
High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan.在日本,幽门螺杆菌感染患者中抗CagA抗体的高血清阳性率与消化性溃疡和正常黏膜无关。
Dig Dis Sci. 1997 Sep;42(9):1841-7. doi: 10.1023/a:1018846723379.
4
The complete genome sequence of the gastric pathogen Helicobacter pylori.胃病原体幽门螺杆菌的全基因组序列。
Nature. 1997 Aug 7;388(6642):539-47. doi: 10.1038/41483.
5
High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients.日本无症状患者和胃癌患者中CagA阳性幽门螺杆菌菌株的高流行率。
Scand J Gastroenterol. 1997 May;32(5):465-8. doi: 10.3109/00365529709025082.
6
Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia.在中国消化性溃疡病患者和慢性胃炎相关性消化不良患者中,cagA 阳性幽门螺杆菌感染的患病率同样很高。
J Clin Microbiol. 1997 Jun;35(6):1344-7. doi: 10.1128/jcm.35.6.1344-1347.1997.
7
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.CagA阳性或CagA阴性幽门螺杆菌感染人群患胃癌的风险。
Gut. 1997 Mar;40(3):297-301. doi: 10.1136/gut.40.3.297.
8
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.cag是幽门螺杆菌的一个致病岛,编码I型特异性和疾病相关的毒力因子。
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53. doi: 10.1073/pnas.93.25.14648.
9
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells.幽门螺杆菌picB是百日咳博德特氏菌毒素分泌蛋白的同源物,是诱导胃上皮细胞中白细胞介素-8所必需的。
Mol Microbiol. 1995 Dec;18(5):867-76. doi: 10.1111/j.1365-2958.1995.18050867.x.
10
Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States.与美国相比,从韩国获得的幽门螺杆菌cagA基因的等位基因变异。
Am J Gastroenterol. 1996 Jul;91(7):1322-5.